American Century Companies Inc. Grows Holdings in Haleon plc (NYSE:HLN)

American Century Companies Inc. lifted its holdings in shares of Haleon plc (NYSE:HLN - Free Report) by 6.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 719,890 shares of the company's stock after purchasing an additional 41,189 shares during the period. American Century Companies Inc.'s holdings in Haleon were worth $6,868,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the stock. Sierra Ocean LLC acquired a new stake in shares of Haleon during the fourth quarter valued at $26,000. Versant Capital Management Inc boosted its stake in shares of Haleon by 2,029.1% during the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company's stock worth $34,000 after purchasing an additional 3,348 shares during the last quarter. Toronto Dominion Bank grew its holdings in shares of Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company's stock worth $38,000 after buying an additional 3,470 shares in the last quarter. Geneos Wealth Management Inc. acquired a new position in shares of Haleon in the fourth quarter valued at approximately $35,000. Finally, Spire Wealth Management purchased a new position in shares of Haleon during the 4th quarter worth $39,000. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently commented on HLN. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Haleon in a research note on Monday, March 3rd. Morgan Stanley lowered shares of Haleon from an "overweight" rating to an "equal weight" rating in a report on Friday, January 10th. Hsbc Global Res downgraded shares of Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. Sanford C. Bernstein lowered shares of Haleon from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 8th. Finally, HSBC reiterated a "hold" rating on shares of Haleon in a report on Wednesday, March 5th. Six investment analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $10.95.

Remove Ads

Haleon Trading Down 6.1 %

HLN traded down $0.61 during trading on Monday, hitting $9.29. 16,205,781 shares of the company's stock were exchanged, compared to its average volume of 10,547,612. Haleon plc has a 1 year low of $7.99 and a 1 year high of $10.80. The stock has a 50 day moving average price of $10.03 and a 200 day moving average price of $9.86. The firm has a market cap of $41.95 billion, a P/E ratio of 27.34, a price-to-earnings-growth ratio of 2.82 and a beta of 0.24. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44.

Haleon (NYSE:HLN - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The firm had revenue of $3.54 billion during the quarter, compared to analysts' expectations of $3.38 billion. As a group, analysts expect that Haleon plc will post 0.43 EPS for the current fiscal year.

Haleon Increases Dividend

The business also recently announced a -- dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be issued a dividend of $0.1166 per share. This is an increase from Haleon's previous -- dividend of $0.05. This represents a dividend yield of 1.6%. The ex-dividend date is Friday, April 25th. Haleon's dividend payout ratio (DPR) is presently 58.97%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.